Director Lori Kunkel resigns from Curis board citing fundamental disagreement on operations

CURIS INC

Resignation effective September 30, 2022; she served on Nominating/Corporate Governance and chaired Clinical Program Committee.
Resignation attributed to fundamental difference in belief on company operations.
Company provided Dr. Kunkel opportunity to furnish letter confirming or disagreeing with company's statements.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lori A. Kunkel, M.D.

Director

CRIS · CURIS INC

Effective: 2022-09-30
Filed: September 22, 2022, 7:59 PM ET

On September 19, 2022 , Lori A. Kunkel, M.D. submitted her written resignation (the “Resignation Letter”) from the Board of Directors (the “Board”) of Curis, Inc. (the “Company”) effective September 30, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lori A. Kunkel, M.D. departed as Director at CURIS INC.

Action: resignation
Role: Director

Exact text from the filing

On September 19, 2022 , Lori A. Kunkel, M.D. submitted her written resignation (the “Resignation Letter”) from the Board of Directors (the “Board”) of Curis, Inc. (the “Company”) effective September 30, 2022.

View on SEC.gov

CURIS INC filing history →

Source: SEC EDGAR

accession 0001108205-22-000012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.